Terms: = Brain cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
12 results:
1. Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion.
Huan R; Zhang J; Yue J; Yang S; Han G; Cheng Y; Tan Y
J Cell Mol Med; 2024 May; 28(9):e18318. PubMed ID: 38685674
[TBL] [Abstract] [Full Text] [Related]
2. Transferrin receptor 1 targeted nanomedicine for brain tumor therapy.
Li J; Zhang Z; Zhang B; Yan X; Fan K
Biomater Sci; 2023 May; 11(10):3394-3413. PubMed ID: 36847174
[TBL] [Abstract] [Full Text] [Related]
3. brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma.
Jia W; Tian H; Jiang J; Zhou L; Li L; Luo M; Ding N; Nice EC; Huang C; Zhang H
Small; 2023 Jan; 19(2):e2205354. PubMed ID: 36399643
[TBL] [Abstract] [Full Text] [Related]
4. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract] [Full Text] [Related]
5. Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.
Liu W; Lin Q; Fu Y; Huang S; Guo C; Li L; Wang L; Zhang Z; Zhang L
J Control Release; 2020 Jul; 323():191-202. PubMed ID: 31838201
[TBL] [Abstract] [Full Text] [Related]
6. Elucidation and Structural Modeling of cd71 as a Molecular Target for Cell-Specific Aptamer Binding.
Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
[TBL] [Abstract] [Full Text] [Related]
7. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract] [Full Text] [Related]
8. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract] [Full Text] [Related]
9. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
[TBL] [Abstract] [Full Text] [Related]
10. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.
Lazari D; Alexiou GA; Markopoulos GS; Vartholomatos E; Hodaj E; Chousidis I; Leonardos I; Galani V; Kyritsis AP
J Neurooncol; 2017 May; 132(3):373-381. PubMed ID: 28365838
[TBL] [Abstract] [Full Text] [Related]
11. Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment.
Voth B; Nagasawa DT; Pelargos PE; Chung LK; Ung N; Gopen Q; Tenn S; Kamei DT; Yang I
J Clin Neurosci; 2015 Jul; 22(7):1071-6. PubMed ID: 25891893
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract] [Full Text] [Related]
